Cite

HARVARD Citation

    Mahoney, K. et al. (n.d.). 1113. Clinical and Virologic Outcomes with Early Adintrevimab (ADI) Monoclonal Antibody Therapy in Mild and Moderate COVID-19. Open forum infectious diseases. p. . [Online]. 
  
Back to record